“What would be left of me?” Patient perspectives on the risks of obesity treatment: An Innovative Health Initiative Stratification of Obesity Phenotypes to Optimise Future Obesity Therapy (IMI2 SOPHIA) qualitative study.

The uptake of obesity treatments remains disproportionally low in people living with the disease, even with the advent and availability of GLP-1 agonists in recent years. Efforts to understand this discrepancy have centred on literature syntheses and Healthcare Professionals' (HCPs) perspectives on the barriers to obesity treatment. This study focuses on patient perspectives on the